Vironix AI

Vironix AI

Remote patient monitoring for chronic care

Overview

Vironix AI offers a virtual care platform for healthcare providers to remotely monitor patients with chronic diseases using RPM, RTM, CCM, PCM, CCCM and a staff monitoring service. The system collects home health data and uses validated algorithms and proprietary scores to risk-stratify patients, directing care where needed, with an automated CMS claims workflow to speed reimbursement. It differentiates itself by offering the full suite of chronic care programs plus risk stratification and outsourcing of monitoring staff. The goal is to improve patient outcomes through at-home monitoring and timely interventions while helping providers extend care and secure reimbursement.

About Vironix AI

Simplify's Rating
Why Vironix AI is rated
C-
Rated C on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

51-200

Company Stage

Seed

Total Funding

$280K

Headquarters

New York City, New York

Founded

2020

Get referred to Vironix AI

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Vironix added SVP Jason McWhorter on August 26, 2026, signaling operating expansion.
  • CDIN launched Vironix virtual care across Las Vegas and Henderson in March 2026.
  • Vironix updated its site on September 2, 2026, showing active commercial momentum.

What critics are saying

  • PitchBook shows only $3.38 million raised; scaling national sales needs more capital.
  • Public web presence lacks independent customer retention, revenue, or clinical-outcome disclosure.
  • If Medicare RPM reimbursement rules tighten after 2026, Vironix's provider economics collapse.

What makes Vironix AI unique

  • Oxford partnership since 2023 validates Vironix's CKD and heart-failure prediction models.
  • Exela collaboration since 2025 ties clinical monitoring to revenue-cycle automation.
  • Vironix bundles devices, software, and monitoring staff for turnkey provider programs.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$280k

Below

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Below Average

Industry standards

$3.3M
$280k
Vironix AI
$1.5M
Slack
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood

Benefits

Health Insurance

Stock Options

Remote Work Options

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-3%

2 year growth

2%
Vironix AI
Jun 24th, 2025
Remote Monitoring Leadership Council Launches!

Vironix Health celebrates the launch of the Remote Monitoring Leadership Council, a new alliance of digital health CEOs united to advance tech-enabled care and champion the expansion of Remote Patient Monitoring (RPM) across the country.

PMLive
Aug 25th, 2023
Vironix and Oxford University partner to advance chronic kidney disease monitoring

The collaboration comes a year after Vironix announced its partnership with Oxford University to develop novel prediction methods for proactive intervention in congestive heart failure.

PR Newswire
Aug 24th, 2023
Breakthroughs Using Ai For Chronic Kidney Disease Monitoring: Vironix Health And Oxford University

AUSTIN, Texas, Aug. 24, 2023 /PRNewswire/ -- Vironix Health Inc., an innovative leader in AI-powered remote patient monitoring applications for healthcare providers, is bolstering its alliance with the University of Oxford's Mathematical Institute. The collaboration aims squarely at advanced prediction of Chronic Kidney Disease (CKD) progression.Oxford UniversityBuilding on the triumph of last year's synthetic patient data generation project, the partners are setting their sights on CKD, a medical challenge marked by gradual kidney function deterioration. Early interventions leveraging AI can amplify patient well-being, decelerate the disease progression, and reduce healthcare costs. Dr. Sumanth Swaminathan, CEO of Vironix Health, commented on the partnership's potential, remarking, "Vironix is committed to innovating preventive care technologies that prioritize validation through scientific rigor and peer review

HRNXT Media
Mar 15th, 2023
Former BookMyShow CTO Mahesh Vandi Chalil appointed Chief Product and Technology Officer at Cyble | hrnxt.com

Vironix Health, a digital health company, has announced the appointment of Mahesh Visvanathan, MS/MBA as Chief Operations and Business Development Officer to lead its strategic partnership and commercialization strategy.

Recently Posted Jobs

Sign up to get curated job recommendations

Vironix AI is Hiring for 8 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →